The company has more than 80 employees, including a significant number of clinicians. Its software has more than 15 000 users in over 90 countries.
Summary sheet
The promoter develops artificial intelligence (AI) enabled medical documentation technology to efficiently capture, structure and process clinical data at the source. The investment plan will mostly cover the development of the next generation reporting software.
The project will contribute to the digitalisation of healthcare, thereby improving efficiency and quality level, thus creating new possibilities for the use of healthcare data in clinical trials and drug development.
The purpose of the loan is to provide direct equity-type financing under the Research, Innovation and Digitalization window of InvestEU, benefiting from the EC guarantee, to finance research and development activities of an innovative synoptic and data-driven reporting solution Company that speeds up reporting time, enhances reporting quality and improves the communication in radiology and beyond. The financing of this project addresses the failure in financial markets for RDI-driven European SMEs suffering from systemic shortages of large, non-dilutive financing options for growth investments. Creation of knowledge and support of skilled jobs in Germany will further contribute positively towards the EU's 3% RDI intensity target. Currently, the Company does not have access either to non-dilutive or to long-term debt funding sources in the necessary amount. Due to volatility of European markets which has significantly increased in 2022, access to both equity markets and commercial debt providers has been highly limited for innovative but risky companies such as Smart Reporting.
Structuring the financing as venture debt caters to the investment needs of the Company, with a long tenor and deferred interest minimising cash outflows during the investment period, while most of the EIB remuneration will be driven by the equity kicker.
The project concerns investments in research and development activities carried out by the promoter and its partners in existing facilities without changing their already authorised scope. The research and development activities of the project do not fall under either Annex I or Annex II of the Environmental Impact Assessment (EIA) Directive 2011/92/EU amended by Directive 2014/52/EU.
The promoter is a private company not operating in the utilities sector and not having the status of a contracting authority. Thus, it is not covered by EU Directives on procurement. The Bank will require that all project contracts are procured in accordance with the applicable EU procurement legislation.
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).
Documents
News & Stories
Inside the project
How and Why
Minimising time spent on documentation
Why
- The average doctor spends more than a third of their working hours on documentation
- 40% of European doctors are close to retirement age, so Europe has a looming physician shortage
- Radiologists are particularly in demand. Over 80% of health systems report radiology shortages
How
- Smart Reporting uses digital technology to standardise reporting and minimise time spent on documentation
- The company works with software engineers and clinicians to develop templates that could be updated regularly
- The templates include predetermined fields to input relevant information, as well as clinical background information and most recent research available on the topic
- The software is voice-controlled, so doctors operate it without a single click
Sectors & Countries
Play video
1:05
The company’s system could prove very useful for less specialised doctors in smaller hospitals who will be able to pick a relevant template to assess the patient, allowing them to make more informed decisions and diagnoses.
Maybe, we will be able to prevent the next pandemic.
Related media
The invisible made visible
Doctors spend third of their time on documentation. A German health tech startup uses artificial intelligence to cut time spent on medical reports and improve patient care
Health Solutions: The pandemic next time
Even before COVID-19 is beaten, it’s time for governments, scientists, health systems and financial and development institutions to assess the lessons of the coronavirus and set new standards for pandemic preparedness
Health Solutions: Caught out by a pandemic
Creating the infrastructure to develop quick, new diagnostics was a major achievement of the COVID-19 pandemic. But we need to keep financing innovation to be ready for the next big one.
Related projects and stories
EIB and EIF Boards of Directors meet in Warsaw to discuss new financing initiatives and affirm solidarity in the aftermath of floods
The Boards of Directors of the European Investment Bank (EIB) and the European Investment Fund (EIF) gathered in Warsaw on 30 September and 1 October, to meet local authorities and discuss new initiatives and financing instruments that will help channel savings into productive investment for the benefit of Europe’s economies. In meetings with Polish officials, EIB Group President Nadia Calviño reiterated that the EU’s financial arm is ready to support reconstruction works in the aftermath of the recent catastrophic floods, and further scale up the financing for climate resilience projects in Poland and Central Europe.
Seeds for local growth
EIB Global helps female entrepreneurs get loans from Kenya’s regional banks, boosting small business
Montenegro’s digital transition starts at school
Improving education in Montenegro with Team Europe support
General enquiries and comments
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.
Media enquiries
Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.
Complaints mechanism
Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.
Zero tolerance against fraud and corruption
The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.
Related publications